Publications

You can use the filters to show only results that match your interests

Filter publications
341 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Notified bodies for medical devices

  2. Medical devices: UK notified bodies

  3. Suspended and revoked licences for manufacturers and wholesalers of medicines

  4. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  5. Better consultations, better evidence

    • MHRA
    • Research and analysis
  6. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  7. Human and veterinary medicines: register of licensed manufacturing sites 2017

  8. Human and veterinary medicines: register of licensed wholesale distribution sites

  9. Advertising investigations: May 2017

  10. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Open consultation
  11. Early access to medicine scheme (EAMS) scientific opinion: Oxervate for the treatment of moderate or severe neurotrophic keratitis

  12. Parallel import licences granted in May 2017

  13. Marketing authorisations granted in May 2017

  14. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  15. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  16. Register of brokers authorised to deal in human medicines

  17. Medicines: new manufacturing and wholesale dealer licences

  18. MHRA: business impact target

    • MHRA
    • Research and analysis
  19. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  20. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  21. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  22. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  23. Advertising investigations: April 2017

  24. Marketing authorisations granted in April 2017

  25. Parallel import licences granted in April 2017

  26. Early access to medicines scheme (EAMS) scientific opinion: Glecaprevir/Pibrentasvir for the treatment of chronic hepatitis C (HCV) infection in adults

  27. Advertising investigations: March 2017

  28. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2016 to 2017

    • MHRA
    • Transparency data
  29. Medical devices: software applications (apps)

  30. Medicines and Healthcare products Regulatory Agency Business Plan 2017 to 18

    • MHRA
    • Corporate report
  31. Good manufacturing practice inspection deficiencies

    • MHRA
    • Official Statistics
  32. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  33. Patient group directions (PGDs)

    • MHRA
    • Guidance
  34. Parallel import licences granted in March 2017

  35. Marketing authorisations granted in March 2017

  36. Toolkit on the risks of valproate medicines in female patients

  37. MHRA fees

    • MHRA
    • Statutory guidance
  38. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  39. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Closed consultation
  40. Medical devices: Virtual Manufacturing replaces Own Brand Labelling